PE Firm, Pharma Cos. Fight £31M Fine For Colluding Over Drug
Three pharmaceutical companies and a private equity group fined over alleged price gouging accused the U.K.'s antitrust regulator at an appeal Monday of mischaracterizing and misinterpreting evidence in an "eagerness to...To view the full article, register now.
Already a subscriber? Click here to view full article